Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $13.04 MXN
Change Today -0.15 / -1.14%
Volume 2.1M
As of 12:44 PM 10/8/15 All times are local (Market data is delayed by at least 15 minutes).

genomma lab internacional-b (LABB) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/31/14 - $34.20
52 Week Low
03/4/15 - $8.75
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

genomma lab internacional-b (LABB) Related Businessweek News

No Related Businessweek News Found

genomma lab internacional-b (LABB) Details

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, develops, markets, and sells over-the-counter pharmaceutical products, generic drugs, and personal care products in Mexico and internationally. The company offers approximately 83 own brands covering various product categories, including anti-acne products, generic drugs, sexual protection and enhancement products, hemorrhoid treatments, varicose vein treatments, hair loss treatments, topical analgesics, antacids, topical antifungals, colitis treatments, anti stress treatments, soaps, multivitamins, shampoos, and flu treatments, as well as creams to enhance the appearance of scars. It also provides air transportation services. The company was founded in 1996 and is based in Mexico City, México.

Founded in 1996

genomma lab internacional-b (LABB) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

genomma lab internacional-b (LABB) Key Developments

Genomma Lab Cuts 395 Jobs, Representing 38% of its Staff

Genomma Lab has announced that it has cut 395 jobs, representing 38% of its staff.

Genomma Lab Internacional SAB de CV Presents at Credit Suisse 9th Annual Mid-Summer LatAm Conference, Aug-05-2015

Genomma Lab Internacional SAB de CV Presents at Credit Suisse 9th Annual Mid-Summer LatAm Conference, Aug-05-2015 . Venue: Omni Berkshire Place Hotel, 21 East 52nd Street at Madison Avenue, New York, NY 10022, United States.

Genomma Seeks Partner

Genomma Lab Internacional SAB de CV (BMV:LAB B) is seeking partner. Kimberly Clark is considering to license some of the non core brands of Genomma Lab that is seeking a partner for this OTC business. Genomma is to focus in core brands. On the other hand Kimberly has improved its performance in Mexico from April - June to 10.2% on net sales and 165% on EBIITDA.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LABB:MM $13.05 MXN -0.14

LABB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LABB.
View Industry Companies

Industry Analysis


Industry Average

Valuation LABB Industry Range
Price/Earnings 9.2x
Price/Sales 1.1x
Price/Book 1.2x
Price/Cash Flow 8.9x
TEV/Sales 0.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENOMMA LAB INTERNACIONAL-B, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at